Caplin Point Laboratories Q1 Results
- BSE: 524742
- NSE: CAPLIPOINT
- ISIN: INE475E01026
- Sector: Biotechnology & Drugs
BSE
2,162.55
149.45 (7.42%)
149.45 (7.42%)Volume34.17 K
Updated: Mon 19 May, 2025 | 15:40:58
NSE
2,161.10151.10 (7.52%)
151.10 (7.52%)Volume5.88 L
Updated: Mon 19 May, 2025 | 15:49:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Caplin Point Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 458.96 | 502.45 | 1.27% | 458.96 | N/A |
| Selling/ General/ Admin Expenses Total | 40.15 | 46.51 | 9.19% | 40.15 | N/A |
| Depreciation/ Amortization | 15.96 | 17.04 | -2.68% | 15.96 | N/A |
| Other Operating Expenses Total | 81.52 | 86.68 | 1229.85% | 81.52 | N/A |
| Total Operating Expense | 323.11 | 351.43 | -0.39% | 323.11 | N/A |
| Operating Income | 135.85 | 151.02 | 5.45% | 135.85 | N/A |
| Net Income Before Taxes | 154.38 | 176.67 | 5.72% | 154.38 | N/A |
| Net Income | 123.98 | 142.57 | 1.97% | 123.98 | N/A |
| Diluted Normalized EPS | 16.32 | 18.69 | 2.66% | 16.32 | N/A |